Taxonomic Unit assignments were made using the biobakery 16S uparse workflow. Associations between patient characteristics and microbial community composition (using Bray Curtis distance) were evaluated by PERMANOVA, and with individual taxa by MaAsLiN. Women with > 50% of sequences from Lactobacillus species were considered to have a Lactobacillus dominant microbiome. This was compared between groups using chi-square or logistic regression. RESULTS: The cohort included 59 women with IBD (28 UC, 27 CD, 4 IC) and 27 controls. A majority, 76 (88%) were Caucasian; 27 (46%) with IBD and 6 (22%) controls were menopausal. In the overall cohort, the composition of the vaginal microbiota did not vary significantly by IBD diagnosis or severity of IBD but did vary by age (p¼ 0.001). After stratifying by menopause, Bray-Curtis dissimilarity was significantly associated with IBD diagnosis in premenopausal women (p¼0.02) but not postmenopausal women (p¼0.1). Lactobacillus dominance varied by IBD diagnosis: UC 11/28 (39%), CD 11/25 (44%), IC 1/4 (25%), controls 27/27 (100%) (p<0.001). In a multivariable model adjusted for menopause, Lactobacillus dominance was associated with both IBD diagnosis (p¼ 0.045) and disease severity (p¼ 0.005). By MaAsLin analysis, vaginal abundance of Proteus, B. fragilis, Clostridia, and Lactobacillus was lower in women with IBD than in healthy controls. CONCLUSIONS: Premenopausal women with IBD have a significantly different vaginal microbiome than healthy controls, due in part to less Lactobacillus dominance.
OBJECTIVES:
Lubricants have been associated with rectal acquisition of sexually transmitted infections. Limited data suggest that lubricants may damage mucosal surfaces and alter the vaginal microbiota. Despite widespread use, the impact of lubricants on the vaginal microenvironment, inflammation and immunity is understudied. We compared women's vaginal immunological profiles before and after either vaginal lubricant use or condomless vaginal sex. METHODS: Reproductive-age women were recruited to a 10-week observational cohort study and self-collected vaginal samples and behavioral diaries daily. This analysis used samples collected the day before and after vaginal lubricant use (cases) versus those collected before and after condomless vaginal sex without lubricant (controls). Controls were matched on age and race. Swabs were frozen dry, then re-suspended in 1ml of PBS. 50ul aliquots were analyzed with a magnetic bead 41-plex panel assay (Millipore HCYT-MAG60PMX41BK) and a Bio-Plex 200 array reader. Wilcoxon signed-rank, Fisher's exact, Chi2, McNemar's and Stuart-Maxwell tests were used to examine baseline differences in vaginal cytokine levels between cases and controls and differences in cytokines and chemokines pre and post exposure. Generalized linear multilevel models were used to assess differences in individual cytokines before and after exposure, and by case-control status. RESULTS: Paired pre-and post-exposure samples from 37 lubricant users and 37 controls were analyzed. 67.6% were African American. Mean age was 30 (SD 6.6). Prior to exposure, vaginal cytokine profiles were similar in cases and controls with the exception of FLT-3 ligand, which was detected in a higher proportion of the lubricant users. There were no statistically significant changes in cytokines before and after exposure in cases or controls. In multilevel modeling, the relative pre-to-post change of cytokines was lower in cases vs. controls for interferon alpha, FLT-3 ligand and eotaxin 14 (p<0.05). CONCLUSIONS: There was little change in cytokine profiles in lubricant users or the condomless sex comparator group before and after exposure. However, we lacked information on osmolarity (hyperosmolar lubricants may be more damaging) and specific ingredients (e.g. antibacterial compounds) in the lubricants used. Future research should evaluate the effect of osmolarity and particular lubricant components on the vaginal immunologic microenvironment, as well as the vaginal microbiota.
22 Role of amniocentesis in the diagnosis of congenital zika syndrome M. Maykin, J. P. Pereira Jr., M. Moreira, K. Nielsen-Saines, S. Gaw1 OBJECTIVES: To describe the role of amniocentesis in diagnosing prenatal Zika virus infection in pregnant women with suspected infection by symptoms and/or abnormal fetal ultrasound findings. METHODS: This is a descriptive case series of 16 women in Rio de Janeiro, Brazil who presented with symptoms and/or abnormal fetal ultrasound suggestive of Zika infection. All study participants underwent amniocentesis and amniotic fluid was tested for Zika virus by RT-PCR. Pregnancy and delivery outcomes were followed and when possible, umbilical cord blood, placenta, or neonatal blood or urine, were tested for Zika virus infection after delivery. RESULTS: Between December 2015 and October 2016, there were 16 patients with either clinically suspected Zika virus infection (fever, arthralgia, rash) with or without fetal anomalies on ultrasound examination that were referred to a national referral center of the Ministry of Health serving Rio de Janeiro State. In total, nine women had Zika as their final diagnosis. Seven of the 16 patients had positive Zika virus on RT-PCR of amniotic fluid. Two of the 9 patients who tested negative at time of amniocentesis had a subsequent positive Zika test on post-natal specimen testing. Thirteen of the 16 patients reported symptoms, and all but one patient developed symptoms in the first trimester. The range of Zika detection ranged from as early as 11 weeks and as late as 18 weeks after suspected infection. CONCLUSIONS: Amniocentesis may detect Zika infection within a wide time interval after suspected infection; however, amniocentesis may not be a reliable form of testing as results can be negative in infections that are later identified on postnatal testing.
23 Wound complications after cesarean delivery associated with prepregnancy extreme obesity
T. Kawakita, S. Iqbal
Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, DC OBJECTIVES: Previously published studies showed increased wound complications in morbidly obese women. However, these data are more than 10 years ago when the use of preoperative antibiotics were not considered a standard of care. In addition, association between gestational weight gain (GWG), defined by Institute of Medicine (IOM) guidelines and wound complications is not studied well. We sought to examine the rates of wound complications according to prepregnancy body mass index (BMI kg/m 2 ) categories and GWG categories.
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